Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Data Collection in Multiple Sclerosis: The MSDS Approach
Tjalf Ziemssen, Raimar Kern, Isabel Voigt, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Digital Twins for Multiple Sclerosis
Isabel Voigt, Hernán Inojosa, Anja Dillenseger, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 188
Digital Biomarkers in Multiple Sclerosis
Anja Dillenseger, Marie Luise Weidemann, Katrin Trentzsch, et al.
Brain Sciences (2021) Vol. 11, Iss. 11, pp. 1519-1519
Open Access | Times Cited: 79
Electronic Health Interventions in the Case of Multiple Sclerosis: From Theory to Practice
Maria Scholz, Rocco Haase, Dirk Schriefer, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 180-180
Open Access | Times Cited: 36
Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple Sclerosis
Olaf Hoffmann, Friedemann Paul, Rocco Haase, et al.
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 455-466
Open Access | Times Cited: 5
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study
Tjalf Ziemssen, Ann Bass, Bart Van Wijmeersch, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Global assessment of characteristics of multiple sclerosis registries; A systematic review
Sajjad Ghane Ezabadi, Mohammad Ali Sahraian, Hossein Maroufi, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103928-103928
Closed Access | Times Cited: 14
Digital Phenotypes of Instability and Fatigue Derived From Daily Standing Transitions in Persons With Multiple Sclerosis
Tyler VanDyk, Brett M. Meyer, Paolo DePetrillo, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering (2023) Vol. 31, pp. 2279-2286
Open Access | Times Cited: 8
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study
Martin S. Weber, Mathias Buttmann, Sven G. Meuth, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 13
The Association of Age, Sex, and BMI on Lower Limb Neuromuscular and Muscle Mechanical Function in People with Multiple Sclerosis
Anne Geßner, Maximilian Hartmann, Katrin Trentzsch, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 971-971
Open Access | Times Cited: 2
Standardization and digitization of clinical data in multiple sclerosis
Marcus D’Souza, Athina Papadopoulou, Christophe Girardey, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 2, pp. 119-125
Closed Access | Times Cited: 16
The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice
Katrin Trentzsch, Marie Luise Weidemann, Charlotte Torp, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 17
Multiple sclerosis and computational biology (Review)
Io Diakou, Eleni Papakonstantinou, Louis Papageorgiou, et al.
Biomedical Reports (2022) Vol. 17, Iss. 6
Open Access | Times Cited: 9
Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health data
Stanislas Demuth, Chadia Ed‐Driouch, Cédric Dumas, et al.
European Journal of Neurology (2024)
Open Access | Times Cited: 1
Improving Digital Patient Care: Lessons Learned from Patient-Reported and Expert-Reported Experience Measures for the Clinical Practice of Multidimensional Walking Assessment
Maria Scholz, Rocco Haase, Katrin Trentzsch, et al.
Brain Sciences (2021) Vol. 11, Iss. 6, pp. 786-786
Open Access | Times Cited: 10
Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study
Tjalf Ziemssen, Frank Hoffmann, Stephan Richter, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 9
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
Helmut Butzkueven, Jan Hillert, Merja Soilu‐Hänninen, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 10, pp. 1367-1374
Open Access | Times Cited: 3
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany
Tjalf Ziemssen, Stephan Richter, Mathias Mäurer, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 5
The transitional phase of multiple sclerosis: The concept of PANGAEA 2.0 evolution study
Hernán Inojosa, Benedict Rauser, Benjamin Ettle, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 46, pp. 102523-102523
Closed Access | Times Cited: 6
Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study
Jan Hillert, Helmut Butzkueven, Melinda Magyari, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 717-732
Open Access
Sensitive Identification of Asymmetries and Neuromuscular Deficits in Lower Limb Function in Early Multiple Sclerosis
Anne Geßner, Maximilian Hartmann, Anikó Vágó, et al.
Neurorehabilitation and neural repair (2024) Vol. 38, Iss. 8, pp. 570-581
Open Access
Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS)
Marco Ghiani, Evi Zhuleku, Anja Dillenseger, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1441-1441
Open Access | Times Cited: 1
Digital medicine in neurological research—Between hype and evidence
Lars Masanneck, Marc Pawlitzki, Sven G. Meuth
Der Nervenarzt (2023) Vol. 95, Iss. 3, pp. 230-235
Closed Access | Times Cited: 1
Multiple Sclerosis: Systemic Challenges to Cost-Effective Care.
David R Weinstein, Gary M. Owens, Ankit M Gandhi
PubMed (2022) Vol. 15, Iss. 1, pp. 13-20
Closed Access | Times Cited: 2
Digital Phenotypes of Instability and Fatigue Derived from Daily Standing Transitions in Persons with Multiple Sclerosis
Tyler VanDyk, Brett C. Meyer, Paolo B. DePetrillo, et al.
(2022)
Open Access | Times Cited: 2
Der Patient als Experte
Rocco Haase, Dirk Schriefer, Tjalf Ziemssen
DNP - Der Neurologe und Psychiater (2020) Vol. 21, Iss. 5, pp. 33-36
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top